Border to Coast Pensions Partnership’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-201,304
Closed -$7.38M 85
2023
Q2
$7.38M Hold
201,304
0.19% 83
2023
Q1
$8.21M Sell
201,304
-464,038
-70% -$20M 0.22% 83
2022
Q4
$34.1M Sell
665,342
-70,000
-10% -$3.36M 1.09% 32
2022
Q3
$32.2M Hold
735,342
1.04% 33
2022
Q2
$38.7M Buy
735,342
+145,664
+25% +$7.42M 1.2% 25
2022
Q1
$30.5M Sell
589,678
-69,296
-11% -$3.6M 0.87% 43
2021
Q4
$38.9M Hold
658,974
1.31% 19
2021
Q3
$38.7M Sell
658,974
-110,000
-14% -$4.87M 1.32% 19
2021
Q2
$30.3M Buy
+768,974
New +$29.9M 1.06% 25

Other funds holding PFE

Border to Coast Pensions Partnership's PFE Position: Q3 2023 in Review

Border to Coast Pensions Partnership sold out of Pfizer (PFE) in Q3 2023, closing a stake of 201,304 shares — an estimated $7.38M sold.

Border to Coast Pensions Partnership first reported a position in PFE in Q2 2021 and held it in 9 quarters. The position peaked at $38.9M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Border to Coast Pensions Partnership reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • Border to Coast Pensions Partnership sold 201,304 Pfizer shares in Q3 2023, an estimated $7.38M.
  • Border to Coast Pensions Partnership first reported a position in Pfizer in Q2 2021 and held it in 9 quarters.
  • Border to Coast Pensions Partnership's Pfizer position peaked at $38.9M in Q4 2021.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Border to Coast Pensions Partnership's 13F filing for Q3 2023, filed 10 Oct 2023.